Annovis Stock Price on April 11, 2022 Breakdown

ANVS
 Stock
  

USD 11.34  0.34  3.09%   

As of today, the current price of Annovis Bio is  11.34 , as last reported on the 7th of August, with the highest price reaching  11.39  and the lowest price hitting  10.88  during the day.
Annovis Bio appears to be not too volatile, given 3 months investment horizon. Annovis Bio secures Sharpe Ratio (or Efficiency) of 0.0643, which signifies that the company had 0.0643% of return per unit of risk over the last 3 months. Our standpoint towards foreseeing the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Annovis Bio, which you can use to evaluate the future volatility of the firm. Please makes use of Annovis Bio's Mean Deviation of 4.74, risk adjusted performance of 0.0824, and Downside Deviation of 5.77 to double-check if our risk estimates are consistent with your expectations.
  
As of 08/07/2022, Net Income Common Stock is likely to drop to about (14.9 M). As of 08/07/2022, Price to Book Value is likely to grow to 3.81, while Price to Earnings Ratio are likely to drop (9.99) . Annovis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Most Recent Activity

Shares Float
5.6 M
Shares Outstanding
8.2 M
Shares Short Prior Month
188 K
Earnings Share
-2.17
Shares Short
247.9 K

Related Headline

Regeneron Pharmaceuticals Headline on 11th of April 2022

Filed transaction by Regeneron Pharmaceuticals officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Annovis Bio Valuation on April 11, 2022

It is possible to determine the worth of Annovis Bio on a given historical date. On April 11, 2022 Annovis was worth 12.21 at the beginning of the trading date compared to the closed value of 11.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Annovis Bio stock. Still, in general, we apply an absolute valuation method to find Annovis Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Visa where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Annovis Bio's related companies.
 Open High Low Close Volume
  12.70    13.22    11.94    12.17    35,339  
04/11/2022
  12.21    12.23    11.34    11.70    56,890  
  12.01    12.40    11.65    12.12    36,595  
Backtest Annovis Bio  |  Annovis Bio History  |  Annovis Bio Valuation   PreviousNext  
Open Value 12.21
11.7
Closing Value
31.32
Upside

Annovis Bio Trading Date Momentum on April 11, 2022

On April 12 2022 Annovis Bio was traded for  12.12  at the closing time. The top price for the day was 12.40  and the lowest listed price was  11.65 . The trading volume for the day was 36.6 K. The trading history from April 12, 2022 was a factor to the next trading day price gain. The overall trading delta against the next closing price was 3.59% . The overall trading delta against the current closing price is 10.09% .

Annovis Bio Fundamentals Correlations and Trends

By evaluating Annovis Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Annovis Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Annovis financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Annovis Bio Stock history

Annovis Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Annovis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Annovis Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Annovis Bio historical stock prices may prove useful in developing a viable investing in Annovis Bio
Last ReportedProjected for 2022
Weighted Average Shares7.6 M6.1 M
Weighted Average Shares Diluted7.6 M6.1 M
Issuance Purchase of Equity Shares46.7 M50.4 M
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania. Annovis Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 3 people.

Annovis Bio Quarterly Market Capitalization

108.99 Million

Annovis Bio Stock Technical Analysis

Annovis Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Annovis Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Annovis Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Annovis Bio Period Price Range

Low
April 11, 2022
High

 12.21 

  

 11.70 

-0.51-4.18%

Annovis Bio August 7, 2022 Market Strength

Market strength indicators help investors to evaluate how Annovis Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Annovis Bio shares will generate the highest return on investment. By undertsting and applying Annovis Bio stock market strength indicators, traders can identify Annovis Bio entry and exit signals to maximize returns

Annovis Bio Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Annovis stock's direction in advance. Along with the technical and fundamental analysis of Annovis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Annovis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Please continue to Trending Equities. Note that the Annovis Bio information on this page should be used as a complementary analysis to other Annovis Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Annovis Stock analysis

When running Annovis Bio price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Is Annovis Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
92.6 M
Return On Assets
-0.44
Return On Equity
-0.74
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.